Advertisement
Screener

Zoetis Inc. (ZTS) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Zoetis Inc. Financing Cash Flow

Zoetis Inc. (ZTS) reported Financing Cash Flow of -$1.65 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06

  • Zoetis Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$813.00M.
  • Zoetis Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$840.00M.
  • Zoetis Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$495.00M.
  • Zoetis Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$134.00M.
  • Zoetis Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$1.87B.
  • Zoetis Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$2.66B.
  • Zoetis Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$3.11B.
  • Zoetis Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$904.00M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30-$813.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.65B
10-Q · filed 2026-08-06
-$2.15B
derived: sum of 3 quarters · filed 2026-08-06
-$2.28B
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$840.00M
10-Q · filed 2026-05-07
-$1.33B
derived: sum of 2 quarters · filed 2026-05-07
-$1.47B
derived: sum of 3 quarters · filed 2026-05-07
-$2.03B
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$495.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$629.00M
derived: sum of 2 quarters · filed 2026-02-12
-$1.19B
derived: sum of 3 quarters · filed 2026-08-06
-$1.87B
10-K · filed 2026-02-12
2025-09-30-$134.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$698.00M
derived: sum of 2 quarters · filed 2026-08-06
-$1.38B
10-Q · filed 2025-11-04
-$2.12B
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$564.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.24B
10-Q · filed 2026-08-06
-$1.99B
derived: sum of 3 quarters · filed 2026-08-06
-$2.61B
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$677.00M
10-Q · filed 2026-05-07
-$1.42B
derived: sum of 2 quarters · filed 2026-05-07
-$2.05B
derived: sum of 3 quarters · filed 2026-05-07
-$2.81B
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$745.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$1.37B
derived: sum of 2 quarters · filed 2026-02-12
-$2.14B
derived: sum of 3 quarters · filed 2026-02-12
-$2.66B
10-K · filed 2026-02-12
2024-09-30-$628.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$1.39B
derived: sum of 2 quarters · filed 2025-11-04
-$1.92B
10-Q · filed 2025-11-04
-$2.31B
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30-$763.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$1.29B
10-Q · filed 2025-08-05
-$1.68B
derived: sum of 3 quarters · filed 2026-02-12
-$2.10B
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31-$524.00M
10-Q · filed 2025-05-06
-$921.00M
derived: sum of 2 quarters · filed 2026-02-12
-$1.34B
derived: sum of 3 quarters · filed 2026-02-12
-$1.83B
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$397.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$813.00M
derived: sum of 2 quarters · filed 2026-02-12
-$1.31B
derived: sum of 3 quarters · filed 2026-02-12
-$3.11B
10-K · filed 2026-02-12
2023-09-30-$416.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
-$910.00M
derived: sum of 2 quarters · filed 2024-11-04
-$2.71B
10-Q · filed 2024-11-04
-$1.93B
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30-$494.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$2.30B
10-Q · filed 2024-08-06
-$1.52B
derived: sum of 3 quarters · filed 2025-02-13
-$2.04B
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$1.80B
10-Q · filed 2024-05-02
-$1.02B
derived: sum of 2 quarters · filed 2025-02-13
-$1.55B
derived: sum of 3 quarters · filed 2025-02-13
-$2.16B
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$780.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$251.00M
derived: sum of 2 quarters · filed 2025-02-13
-$359.00M
derived: sum of 3 quarters · filed 2025-02-13
-$904.00M
10-K · filed 2025-02-13
2022-09-30-$529.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$1.14B
derived: sum of 2 quarters · filed 2023-11-02
-$1.68B
10-Q · filed 2023-11-02
-$2.00B
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30-$610.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$1.16B
10-Q · filed 2023-08-08
-$1.47B
derived: sum of 3 quarters · filed 2024-02-13
-$2.39B
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31-$545.00M
10-Q · filed 2023-05-04
-$859.00M
derived: sum of 2 quarters · filed 2024-02-13
-$1.78B
derived: sum of 3 quarters · filed 2024-02-13
-$2.07B
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31-$314.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
-$1.23B
derived: sum of 2 quarters · filed 2024-02-13
-$1.52B
derived: sum of 3 quarters · filed 2024-02-13
-$1.86B
10-K · filed 2024-02-13
2021-09-30-$919.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$1.21B
derived: sum of 2 quarters · filed 2022-11-03
-$1.55B
10-Q · filed 2022-11-03
-$2.15B
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$290.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$629.00M
10-Q · filed 2022-08-04
-$1.23B
derived: sum of 3 quarters · filed 2023-02-14
-$1.32B
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$339.00M
10-Q · filed 2022-05-05
-$936.00M
derived: sum of 2 quarters · filed 2023-02-14
-$1.03B
derived: sum of 3 quarters · filed 2023-02-14
$112.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$597.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$690.00M
derived: sum of 2 quarters · filed 2023-02-14
$451.00M
derived: sum of 3 quarters · filed 2023-02-14
$123.00M
10-K · filed 2023-02-14
2020-09-30-$93.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.05B
derived: sum of 2 quarters · filed 2021-11-04
$720.00M
10-Q · filed 2021-11-04
$470.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30$1.14B
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$813.00M
10-Q · filed 2021-08-05
$563.00M
derived: sum of 3 quarters · filed 2022-02-15
$331.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31-$328.00M
10-Q · filed 2021-05-06
-$578.00M
derived: sum of 2 quarters · filed 2022-02-15
-$810.00M
derived: sum of 3 quarters · filed 2022-02-15
-$1.04B
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31-$250.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
-$482.00M
derived: sum of 2 quarters · filed 2022-02-15
-$708.00M
derived: sum of 3 quarters · filed 2022-02-15
-$951.00M
10-K · filed 2022-02-15
2019-09-30-$232.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$458.00M
derived: sum of 2 quarters · filed 2020-11-05
-$701.00M
10-Q · filed 2020-11-05
-$898.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30-$226.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$469.00M
10-Q · filed 2020-08-06
-$666.00M
derived: sum of 3 quarters · filed 2021-02-16
$597.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31-$243.00M
10-Q · filed 2020-05-06
-$440.00M
derived: sum of 2 quarters · filed 2021-02-16
$823.00M
derived: sum of 3 quarters · filed 2021-02-16
$552.00M
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31-$197.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$1.07B
derived: sum of 2 quarters · filed 2021-02-16
$795.00M
derived: sum of 3 quarters · filed 2021-02-16
$533.00M
10-K · filed 2021-02-16
2018-09-30$1.26B
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$992.00M
derived: sum of 2 quarters · filed 2019-11-07
$730.00M
10-Q · filed 2019-11-07
-$237.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30-$271.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$533.00M
10-Q · filed 2019-08-06
-$1.50B
derived: sum of 3 quarters · filed 2020-02-13
-$544.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31-$262.00M
10-Q · filed 2019-05-02
-$1.23B
derived: sum of 2 quarters · filed 2020-02-13
-$273.00M
derived: sum of 3 quarters · filed 2020-02-13
-$337.00M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31-$967.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
-$11.00M
derived: sum of 2 quarters · filed 2020-02-13
-$75.00M
derived: sum of 3 quarters · filed 2020-02-13
-$251.00M
10-K · filed 2020-02-13
2017-10-01$956.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$892.00M
derived: sum of 2 quarters · filed 2018-11-01
$716.00M
10-Q · filed 2018-11-01
$588.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-07-02-$64.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$240.00M
10-Q · filed 2018-08-02
-$368.00M
derived: sum of 3 quarters · filed 2019-02-14
-$492.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-04-02-$176.00M
10-Q · filed 2018-05-02
-$304.00M
derived: sum of 2 quarters · filed 2019-02-14
-$428.00M
derived: sum of 3 quarters · filed 2019-02-14
-$536.00M
derived: sum of 4 quarters · filed 2019-02-14
2016-12-31-$128.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
-$252.00M
derived: sum of 2 quarters · filed 2019-02-14
-$360.00M
derived: sum of 3 quarters · filed 2019-02-14
-$903.00M
10-K · filed 2019-02-14
2016-10-02-$124.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$232.00M
derived: sum of 2 quarters · filed 2017-11-02
-$775.00M
10-Q · filed 2017-11-02
$251.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-07-03-$108.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$651.00M
10-Q · filed 2017-08-08
$375.00M
derived: sum of 3 quarters · filed 2018-02-15
$289.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-04-03-$543.00M
10-Q · filed 2017-05-04
$483.00M
derived: sum of 2 quarters · filed 2018-02-15
$397.00M
derived: sum of 3 quarters · filed 2018-02-15
$306.00M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31$1.03B
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
$940.00M
derived: sum of 2 quarters · filed 2018-02-15
$849.00M
derived: sum of 3 quarters · filed 2018-02-15
$755.00M
10-K · filed 2018-02-15
2015-09-27-$86.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$177.00M
derived: sum of 2 quarters · filed 2016-11-03
-$271.00M
10-Q · filed 2016-11-03
-$313.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-28-$91.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$185.00M
10-Q · filed 2016-08-05
-$227.00M
derived: sum of 3 quarters · filed 2017-02-16
-$265.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-29-$94.00M
10-Q · filed 2016-05-06
-$136.00M
derived: sum of 2 quarters · filed 2017-02-16
-$174.00M
derived: sum of 3 quarters · filed 2017-02-16
-$213.00M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31-$42.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
-$80.00M
derived: sum of 2 quarters · filed 2017-02-16
-$119.00M
derived: sum of 3 quarters · filed 2017-02-16
-$154.00M
10-K · filed 2017-02-16
2014-09-28-$38.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$77.00M
derived: sum of 2 quarters · filed 2015-11-05
-$112.00M
10-Q · filed 2015-11-05
-$140.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-29-$39.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$74.00M
10-Q · filed 2015-08-06
-$102.00M
derived: sum of 3 quarters · filed 2016-02-24
-$134.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-30-$35.00M
10-Q · filed 2015-05-07
-$63.00M
derived: sum of 2 quarters · filed 2016-02-24
-$95.00M
derived: sum of 3 quarters · filed 2016-02-24
-$127.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$60.00M
derived: sum of 2 quarters · filed 2016-02-24
-$92.00M
derived: sum of 3 quarters · filed 2016-02-24
-$200.00M
10-K · filed 2016-02-24
2013-09-29-$32.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$64.00M
derived: sum of 2 quarters · filed 2014-11-10
-$172.00M
10-Q · filed 2014-11-10
-$250.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$32.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
-$140.00M
10-Q · filed 2014-08-12
-$218.00M
derived: sum of 3 quarters · filed 2015-02-27
-$236.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$108.00M
10-Q · filed 2014-05-13
-$186.00M
derived: sum of 2 quarters · filed 2015-02-27
-$204.00M
derived: sum of 3 quarters · filed 2015-02-27
-$257.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$78.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$96.00M
derived: sum of 2 quarters · filed 2015-02-27
-$149.00M
derived: sum of 3 quarters · filed 2015-02-27
-$78.00M
10-K · filed 2015-02-27
2012-09-30-$18.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$71.00M
derived: sum of 2 quarters · filed 2013-11-13
$0.00
10-Q · filed 2013-11-13
2012-07-01-$53.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$18.00M
10-Q · filed 2013-08-14
2012-04-01$71.00M
10-Q · filed 2013-05-15
2011-12-31-$30.00M
10-K · filed 2014-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10